Glyxambi 25 MG / 5 MG Oral Tablet

RxCUI: 1602120
RxNorm name: Glyxambi 25 MG / 5 MG Oral Tablet
Display name: Glyxambi 25 MG / 5 MG Oral Tablet
Full name: Glyxambi 25 MG / 5 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glyxambi	EMPAGLIFLOZIN AND LINAGLIPTIN	Boehringer Ingelheim Pharmaceuticals, Inc.	ddbab689-f76c-488c-9613-4168d41dd730	2026-01-20	Warnings, Adverse reactions	Exact identifier rxcui: 1602120

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ddbab689-f76c-488c-9613-4168d41dd730	Glyxambi 25 MG / 5 MG Oral Tablet	PSN	23	These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 2015	20260120
ddbab689-f76c-488c-9613-4168d41dd730	Glyxambi (empagliflozin 25 MG / linagliptin 5 MG) Oral Tablet	SY	23	These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 2015	20260120
ddbab689-f76c-488c-9613-4168d41dd730	empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]	SBD	23	These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 2015	20260120